Form D · Other Health Care
NeuroVice, Inc.
Charlotte, NC · CIK 0002073574
Offering snapshot reported Jun 20, 2025 · SEC filing
- Reported sold
- $270K Offering amount: $3M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 5, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 20, 2025 | Initial | $270,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-549504
Source: Form D, filed Jun 20, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ashlyn Sanders | Director, Executive |
| Jordan Schindler | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1235 East Blvd Suite E Pmb 2001
Charlotte, NC, 28203
Charlotte, NC, 28203